Titre : Visiteurs des patients

Visiteurs des patients : Questions médicales fréquentes

Termes MeSH sélectionnés :

Doxycycline
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Visiteurs des patients : Questions médicales les plus fréquentes", "headline": "Visiteurs des patients : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Visiteurs des patients : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-31", "dateModified": "2025-03-26", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Visiteurs des patients" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Personnes", "url": "https://questionsmedicales.fr/mesh/D009272", "about": { "@type": "MedicalCondition", "name": "Personnes", "code": { "@type": "MedicalCode", "code": "D009272", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "M01" } } }, "about": { "@type": "MedicalCondition", "name": "Visiteurs des patients", "alternateName": "Visitors to Patients", "code": { "@type": "MedicalCode", "code": "D014789", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Samantha J Chiew", "url": "https://questionsmedicales.fr/author/Samantha%20J%20Chiew", "affiliation": { "@type": "Organization", "name": "Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia." } }, { "@type": "Person", "name": "Paul H Hemsworth", "url": "https://questionsmedicales.fr/author/Paul%20H%20Hemsworth", "affiliation": { "@type": "Organization", "name": "Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia." } }, { "@type": "Person", "name": "Sally L Sherwen", "url": "https://questionsmedicales.fr/author/Sally%20L%20Sherwen", "affiliation": { "@type": "Organization", "name": "Department of Wildlife Conservation and Science, Zoos Victoria, Parkville, VIC, Australia." } }, { "@type": "Person", "name": "Grahame J Coleman", "url": "https://questionsmedicales.fr/author/Grahame%20J%20Coleman", "affiliation": { "@type": "Organization", "name": "Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia." } }, { "@type": "Person", "name": "Vicky Melfi", "url": "https://questionsmedicales.fr/author/Vicky%20Melfi", "affiliation": { "@type": "Organization", "name": "Hartpury University and Hartpury College, Gloucester, United Kingdom." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Potential Association of Doxycycline With the Onset of Primary Sclerosing Cholangitis: A Case Series.", "datePublished": "2022-07-01", "url": "https://questionsmedicales.fr/article/31567143", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MJT.0000000000001065" } }, { "@type": "ScholarlyArticle", "name": "In vitro combination with doxycycline plus antifungals against clinical Mucorales pathogens.", "datePublished": "2023-11-07", "url": "https://questionsmedicales.fr/article/37934403", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s42770-023-01167-z" } }, { "@type": "ScholarlyArticle", "name": "Doxycycline to treat levodopa-induced dyskinesias in Parkinson's disease: a preliminary study.", "datePublished": "2023-05-31", "url": "https://questionsmedicales.fr/article/37257466", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/s-0043-1768668" } }, { "@type": "ScholarlyArticle", "name": "Effect of the Matrix Metalloproteinase Inhibitor Doxycycline on Human Trace Fear Memory.", "datePublished": "2023-02-24", "url": "https://questionsmedicales.fr/article/36759188", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1523/ENEURO.0243-22.2023" } }, { "@type": "ScholarlyArticle", "name": "Doxycycline-doped collagen membranes accelerate in vitro osteoblast proliferation and differentiation.", "datePublished": "2022-12-30", "url": "https://questionsmedicales.fr/article/36585537", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jre.13091" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Personnes", "item": "https://questionsmedicales.fr/mesh/D009272" }, { "@type": "ListItem", "position": 3, "name": "Visiteurs des patients", "item": "https://questionsmedicales.fr/mesh/D014789" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Visiteurs des patients - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Visiteurs des patients", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Visiteurs des patients", "description": "Comment évaluer l'impact des visites sur le patient ?\nQuels signes indiquent qu'un patient a besoin de visites ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Doxycycline&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Visiteurs des patients", "description": "Quels symptômes peuvent s'aggraver sans visites ?\nLes visites peuvent-elles réduire la douleur perçue ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Doxycycline&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Visiteurs des patients", "description": "Comment prévenir l'isolement des patients ?\nQuelles mesures prendre pour des visites sûres ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Doxycycline&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Visiteurs des patients", "description": "Les visites font-elles partie du traitement ?\nComment les hôpitaux gèrent-ils les visites ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Doxycycline&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Visiteurs des patients", "description": "Quelles complications peuvent survenir sans visites ?\nLes visites peuvent-elles causer du stress au patient ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Doxycycline&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Visiteurs des patients", "description": "Quels facteurs augmentent le besoin de visites ?\nLes patients en soins intensifs ont-ils plus besoin de visites ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Doxycycline&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer l'impact des visites sur le patient ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'impact peut être évalué par des questionnaires sur le bien-être et l'état émotionnel." } }, { "@type": "Question", "name": "Quels signes indiquent qu'un patient a besoin de visites ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Un patient peut montrer des signes de solitude, d'anxiété ou de dépression." } }, { "@type": "Question", "name": "Quels symptômes peuvent s'aggraver sans visites ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "L'isolement social peut aggraver l'anxiété et la dépression chez le patient." } }, { "@type": "Question", "name": "Les visites peuvent-elles réduire la douleur perçue ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le soutien émotionnel des visiteurs peut diminuer la perception de la douleur." } }, { "@type": "Question", "name": "Comment prévenir l'isolement des patients ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Encourager les visites régulières et utiliser des technologies de communication." } }, { "@type": "Question", "name": "Quelles mesures prendre pour des visites sûres ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Respecter les protocoles d'hygiène et les restrictions de visite en place." } }, { "@type": "Question", "name": "Les visites font-elles partie du traitement ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les visites peuvent être considérées comme un complément au traitement médical." } }, { "@type": "Question", "name": "Comment les hôpitaux gèrent-ils les visites ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les hôpitaux établissent des horaires et des règles pour assurer la sécurité des patients." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir sans visites ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "L'absence de visites peut entraîner une détérioration de la santé mentale et physique." } }, { "@type": "Question", "name": "Les visites peuvent-elles causer du stress au patient ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des visites non planifiées ou trop fréquentes peuvent causer du stress." } }, { "@type": "Question", "name": "Quels facteurs augmentent le besoin de visites ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "L'âge avancé, les maladies chroniques et l'isolement social augmentent ce besoin." } }, { "@type": "Question", "name": "Les patients en soins intensifs ont-ils plus besoin de visites ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients en soins intensifs peuvent bénéficier davantage du soutien des visiteurs." } } ] } ] }

Sources (473 au total)

Potential Association of Doxycycline With the Onset of Primary Sclerosing Cholangitis: A Case Series.

Primary sclerosing cholangitis (PSC) is linked to inflammatory bowel diseases (IBD). Evidence suggests an association between the gut microbiome and PSC. However, the putative relationship between exp... The etiopathogenesis of PSC remains an enigma.... We collected data from patients with PSC and PSC-IBD in which there seemed to be a temporal relationship between exposure to doxycycline and PSC. Time from doxycycline exposure to: (1) onset of PSC or... We identified 6 additional patients with PSC or PSC-IBD in whom there was a temporal relationship between exposure to doxycycline and onset of PSC or PSC-IBD. The median age of these 9 patients was 20... We describe 9 cases of PSC and PSC-IBD in which there seem to be a temporal relationship between exposure to doxycycline and onset of PSC....

In vitro combination with doxycycline plus antifungals against clinical Mucorales pathogens.

Since systematic antifungals for mucormycosis showed variable MICs depending on strains, effective and safe antifungal therapy was still needed. This study is aimed to evaluate the in vitro activity o... Multidrug susceptibility testing was performed with doxycycline and antifungals, including itraconazole, posaconazole, and amphotericin, in 21 isolates of 8 dominant Mucorales pathogens.... The fractional inhibitory concentration index according to M38 showed one Rhizopus arrhizus isolate synergic (∑FICI = 0.375) and other isolates in addition (0.5 < ∑FICI < 4).... Doxycycline was found to have in vitro advantages in combined antifungal treatment over antifungals alone....

Doxycycline to treat levodopa-induced dyskinesias in Parkinson's disease: a preliminary study.

Levodopa-induced dyskinesia (LID) is a common motor complication of levodopa therapy in patients with Parkinson's disease (PD). Doxycycline is a widely used and inexpensive tetracycline with anti-infl... To evaluate the efficacy and safety of doxycycline in patients with PD and LID.... This was an open-label, uncontrolled, single-arm, single-center, phase 2 proof-of-concept study in patients with PD with functional impact of dyskinesia, which used levodopa three times daily, in a mo... Eight patients with PD were treated and evaluated. Doxycycline 200 mg/day reduced the UDysRS total score at week 12, compared with baseline (Friedman χ... In this preliminary, open-label and uncontrolled trial, doxycycline was effective in reducing LID and safe after a 12-week treatment. Further well-designed placebo-controlled clinical trials with a lo...

Doxycycline-doped collagen membranes accelerate in vitro osteoblast proliferation and differentiation.

The aim of the study was to evaluate the effect of doxycycline- and dexamethasone-doped collagen membranes on the proliferation and differentiation of osteoblasts.... Collagen barrier membranes are frequently used to promote bone regeneration and to boost this biological activity their functionalization with antibacterial and immunomodulatory substances has been su... The design included commercially available collagen membranes doped with doxycycline (Dox-Col-M) or dexamethasone (Dex-Col-M), as well as undoped membranes (Col-M) as controls, which were placed in co... Osteoblast proliferation was significantly enhanced in the functionalized membranes as follows: (Col-M < Dex-Col-M < Dox-Col-M). ALP activity was significantly higher on cultured osteoblasts on Dox-Co... The functionalization of collagen membranes with Dox promoted an increase in the proliferation and differentiation of osteoblasts....

Clinical outcomes of doxycycline, azithromycin and chloramphenicol for the treatment of patients with severe scrub typhus.

Previous studies have evaluated treatment efficacy of various antibiotics for patients with mild-to-moderate scrub typhus (ST). However, the efficacy of different antibiotics for treating severe ST re... A retrospective study of patients with severe ST was undertaken in China. The treatment efficacy rates of doxycycline, azithromycin and chloramphenicol were compared, using treatment failure and time ... In total, 876 patients with severe ST who initially received doxycycline, azithromycin or chloramphenicol were recruited. The treatment failure rate did not differ significantly between patients recei... Azithromycin and doxycycline were found to have significant therapeutic effects in patients with severe ST. In contast, chloramphenicol was less efficacious for the treatment of these patients....

Doxycycline Sclerotherapy of Head and Neck Lymphatic Malformations: Intermediate Report of 27 Cases.

To evaluate the safety and efficacy of percutaneous doxycycline sclerotherapy of head and neck lymphatic malformations (LM) with a 40-month follow-up of 27 cases.... Twenty-seven consecutive patients with head and neck LM who underwent doxycycline sclerotherapy from 2010 to 2019 were retrospectively reviewed. Pre- and peri-interventional data collection included p... Twenty-seven patients underwent a mean of four doxycycline sclerotherapy sessions (range 1-23). The mean total dose of injected doxycycline per session was 170 mg. Maximal diameter of the LM decreased... Ultrasound-guided, percutaneous doxycycline sclerotherapy is a safe and effective method of managing symptomatic LM of the head and neck....